Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Ponticelli

Showing results (201-210 of 210) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 210 results.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 21, 2012
Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: long-term follow-up of the SHIRAKISS randomized, prospective studyLuciano Potena, Paola Prestinenzi, Isidoro G Bianchi, et al.
Journal of the American Society of Nephrology : JASN|September 20, 2001
Long-term results of a randomized study comparing three immunosuppressive schedules with cyclosporine in cadaveric kidney transplantationGiuseppe Montagnino, Antonio Tarantino, Giuseppe P Segoloni, et al.
BMJ Open|December 7, 2019
Rituximab versus steroids and cyclophosphamide for the treatment of primary membranous nephropathy: protocol of a pilot randomised controlled trialFrancesco Scolari, Nadia Dallera, Loreto Gesualdo, et al.
The American Journal of Medicine|March 28, 2017
Post-Discharge Worsening Renal Function in Patients with Type 2 Diabetes and Recent Acute Coronary SyndromeNuccia Morici, Stefano Savonitto, Claudio Ponticelli, et al.
Journal of the American Society of Nephrology : JASN|March 2, 2021
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized TrialFrancesco Scolari, Elisa Delbarba, Domenico Santoro, et al.
Transplantation|November 26, 2009
Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trialMaurizio Salvadori, Maria Piera Scolari, Elisabetta Bertoni, et al.
Kidney International|December 8, 2022
Glomerular diseases in pregnancy: pragmatic recommendations for clinical managementFadi Fakhouri, Nora Schwotzer, Gianfranca Cabiddu, et al.
Nature Genetics|March 15, 2011
Genome-wide association study identifies susceptibility loci for IgA nephropathyAli G Gharavi, Krzysztof Kiryluk, Murim Choi, et al.
Nature Genetics|October 13, 2014
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogensKrzysztof Kiryluk, Yifu Li, Francesco Scolari, et al.
Nature Genetics|June 19, 2023
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathyKrzysztof Kiryluk, Elena Sanchez-Rodriguez, Xu-Jie Zhou, et al.
Pageof 21

Showing results (201-210 of 210) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 210 results.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 21, 2012
Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: long-term follow-up of the SHIRAKISS randomized, prospective studyLuciano Potena, Paola Prestinenzi, Isidoro G Bianchi, et al.
Journal of the American Society of Nephrology : JASN|September 20, 2001
Long-term results of a randomized study comparing three immunosuppressive schedules with cyclosporine in cadaveric kidney transplantationGiuseppe Montagnino, Antonio Tarantino, Giuseppe P Segoloni, et al.
BMJ Open|December 7, 2019
Rituximab versus steroids and cyclophosphamide for the treatment of primary membranous nephropathy: protocol of a pilot randomised controlled trialFrancesco Scolari, Nadia Dallera, Loreto Gesualdo, et al.
The American Journal of Medicine|March 28, 2017
Post-Discharge Worsening Renal Function in Patients with Type 2 Diabetes and Recent Acute Coronary SyndromeNuccia Morici, Stefano Savonitto, Claudio Ponticelli, et al.
Journal of the American Society of Nephrology : JASN|March 2, 2021
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized TrialFrancesco Scolari, Elisa Delbarba, Domenico Santoro, et al.
Transplantation|November 26, 2009
Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trialMaurizio Salvadori, Maria Piera Scolari, Elisabetta Bertoni, et al.
Kidney International|December 8, 2022
Glomerular diseases in pregnancy: pragmatic recommendations for clinical managementFadi Fakhouri, Nora Schwotzer, Gianfranca Cabiddu, et al.
Nature Genetics|March 15, 2011
Genome-wide association study identifies susceptibility loci for IgA nephropathyAli G Gharavi, Krzysztof Kiryluk, Murim Choi, et al.
Nature Genetics|October 13, 2014
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogensKrzysztof Kiryluk, Yifu Li, Francesco Scolari, et al.
Nature Genetics|June 19, 2023
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathyKrzysztof Kiryluk, Elena Sanchez-Rodriguez, Xu-Jie Zhou, et al.
Pageof 21